Dutch guidelines for economic evaluation: ‘from good to better’ in theory but further away from pharmaceuticals in practice?
Author:
Affiliation:
1. CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research ‘Mario Negri’, 24020 Ranica (BG), Italy
Publisher
SAGE Publications
Subject
General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/0141076817690395
Reference45 articles.
1. From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands;The European Journal of Health Economics;2024-03-14
2. A review of heath economic evaluation practice in the Netherlands: are we moving forward?;Health Economics, Policy and Law;2023-06-06
3. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands;JAMA Pediatrics;2023-06-01
4. Recommendations on Pharmacoeconomic guidelines for Turkey considering reference countries: A scoping review;Health Policy and Technology;2022-12
5. Health technology assessment for pharmaceuticals in the European Union: what lessons after two decades?;Internal and Emergency Medicine;2022-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3